These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26282172)

  • 1. Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer.
    Ylipää A; Kivinummi K; Kohvakka A; Annala M; Latonen L; Scaravilli M; Kartasalo K; Leppänen SP; Karakurt S; Seppälä J; Yli-Harja O; Tammela TL; Zhang W; Visakorpi T; Nykter M
    Cancer Res; 2015 Oct; 75(19):4026-31. PubMed ID: 26282172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5.
    Gu P; Chen X; Xie R; Han J; Xie W; Wang B; Dong W; Chen C; Yang M; Jiang J; Chen Z; Huang J; Lin T
    Mol Ther; 2017 Aug; 25(8):1959-1973. PubMed ID: 28487115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional program.
    Parolia A; Venalainen E; Xue H; Mather R; Lin D; Wu R; Pucci P; Rogalski J; Evans JR; Feng F; Collins CC; Wang Y; Crea F
    Mol Oncol; 2019 May; 13(5):1121-1136. PubMed ID: 30776192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer.
    Wang D; Ding L; Wang L; Zhao Y; Sun Z; Karnes RJ; Zhang J; Huang H
    Oncotarget; 2015 Dec; 6(38):41045-55. PubMed ID: 26516927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer.
    Ren S; Liu Y; Xu W; Sun Y; Lu J; Wang F; Wei M; Shen J; Hou J; Gao X; Xu C; Huang J; Zhao Y; Sun Y
    J Urol; 2013 Dec; 190(6):2278-87. PubMed ID: 23845456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lncRNA PTTG3P promotes the progression of CRPC via upregulating PTTG1.
    Huang S; Liao Q; Li W; Deng G; Jia M; Fang Q; Ji H; Meng M
    Bull Cancer; 2021 Apr; 108(4):359-368. PubMed ID: 33743960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex.
    Shang Z; Yu J; Sun L; Tian J; Zhu S; Zhang B; Dong Q; Jiang N; Flores-Morales A; Chang C; Niu Y
    Nucleic Acids Res; 2019 May; 47(8):4211-4225. PubMed ID: 30773595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of ERG protein expression for development of castration-resistant prostate cancer in hormone-naïve advanced prostate cancer treated with primary androgen deprivation therapy.
    Berg KD; Røder MA; Thomsen FB; Vainer B; Gerds TA; Brasso K; Iversen P
    Prostate; 2015 Oct; 75(14):1499-509. PubMed ID: 26053696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen-induced Long Noncoding RNA (lncRNA) SOCS2-AS1 Promotes Cell Growth and Inhibits Apoptosis in Prostate Cancer Cells.
    Misawa A; Takayama K; Urano T; Inoue S
    J Biol Chem; 2016 Aug; 291(34):17861-80. PubMed ID: 27342777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells.
    Kang M; Lee KH; Lee HS; Park YH; Jeong CW; Ku JH; Kim HH; Kwak C
    Prostate; 2016 Feb; 76(3):273-85. PubMed ID: 26499308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linc00963: a novel, long non-coding RNA involved in the transition of prostate cancer from androgen-dependence to androgen-independence.
    Wang L; Han S; Jin G; Zhou X; Li M; Ying X; Wang L; Wu H; Zhu Q
    Int J Oncol; 2014 Jun; 44(6):2041-9. PubMed ID: 24691949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YAP is closely correlated with castration-resistant prostate cancer, and downregulation of YAP reduces proliferation and induces apoptosis of PC-3 cells.
    Sheng X; Li WB; Wang DL; Chen KH; Cao JJ; Luo Z; He J; Li MC; Liu WJ; Yu C
    Mol Med Rep; 2015 Oct; 12(4):4867-76. PubMed ID: 26126522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERG induces taxane resistance in castration-resistant prostate cancer.
    Galletti G; Matov A; Beltran H; Fontugne J; Miguel Mosquera J; Cheung C; MacDonald TY; Sung M; O'Toole S; Kench JG; Suk Chae S; Kimovski D; Tagawa ST; Nanus DM; Rubin MA; Horvath LG; Giannakakou P; Rickman DS
    Nat Commun; 2014 Nov; 5():5548. PubMed ID: 25420520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer.
    Laxman B; Tomlins SA; Mehra R; Morris DS; Wang L; Helgeson BE; Shah RB; Rubin MA; Wei JT; Chinnaiyan AM
    Neoplasia; 2006 Oct; 8(10):885-8. PubMed ID: 17059688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression.
    Latonen L; Afyounian E; Jylhä A; Nättinen J; Aapola U; Annala M; Kivinummi KK; Tammela TTL; Beuerman RW; Uusitalo H; Nykter M; Visakorpi T
    Nat Commun; 2018 Mar; 9(1):1176. PubMed ID: 29563510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of noncoding RNA in prostate cancer progression and its implication on diagnosis and treatment.
    Takayama K; Inoue S
    Brief Funct Genomics; 2016 May; 15(3):257-65. PubMed ID: 26685282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA GAPLINC regulates CD44-dependent cell invasiveness and associates with poor prognosis of gastric cancer.
    Hu Y; Wang J; Qian J; Kong X; Tang J; Wang Y; Chen H; Hong J; Zou W; Chen Y; Xu J; Fang JY
    Cancer Res; 2014 Dec; 74(23):6890-902. PubMed ID: 25277524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkers.
    Dhani NC; Emmenegger U; Adams L; Jongstra J; Tannock IF; Sridhar SS; Knox JJ; Day JR; Groskopf J; Joshua AM
    BJU Int; 2012 Sep; 110(6):840-5. PubMed ID: 22313860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer.
    Sowalsky AG; Xia Z; Wang L; Zhao H; Chen S; Bubley GJ; Balk SP; Li W
    Mol Cancer Res; 2015 Jan; 13(1):98-106. PubMed ID: 25189356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRKAR2B plays an oncogenic role in the castration-resistant prostate cancer.
    Sha J; Xue W; Dong B; Pan J; Wu X; Li D; Liu D; Huang Y
    Oncotarget; 2017 Jan; 8(4):6114-6129. PubMed ID: 28008150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.